Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation

被引：0
|
作者：
Chen, Yuxi [1 ]
Hua, Chen [1 ]
Lin, Xiaoxi [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 13期
关键词：
D O I：
10.1056/NEJMc2410533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1260
页数：2
相关论文
共 50 条
  • [21] The Research Progress of Direct KRAS G12C Mutation Inhibitors
    Yang, Ai
    Li, Min
    Fang, Mingzhi
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [22] ONCOGENIC KRAS G12C MUTATION DERIVED INHIBITOR DEVELOPMENT
    Leveles, Ibolya
    Koppany, Gergely
    Nyiri, Kinga
    Vertessy, G. Beata
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : E117 - E117
  • [23] Sotorasib-modified KRAS G12C MHC I complex as a target for cancer theranostics
    Pandey, Apurva
    Rohweder, Peter
    Chan, Lieza
    Ongpipattanakul, Chayanid
    Paolella, Bryce
    Quimby, Fiona
    Verba, Kliment
    Evans, Michael
    Craik, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [24] Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
    Qunaj, Lindor
    May, Michael S.
    Neugut, Alfred I.
    Herzberg, Benjamin O.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] The Likelihood of Heterogeneity or Additional Mutation to Compromise Targeting of KRAS G12C
    Cannataro, V.
    Gaffney, S.
    Stender, C.
    Zhao, Z.
    Philips, M.
    Greenstein, A.
    Townsend, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1538 - S1538
  • [26] Studies on the molecular mechanisms responsible for cisplatin resistance associated to KRAS G12C mutation in NSCLC
    Caiola, Elisa
    Frapolli, Roberta
    Broggini, Massimo
    Garassino, Marina Chiara
    Farina, Gabriella
    Marabese, Mirko
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [27] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Yulei Zhao
    Yonina R. Murciano-Goroff
    Jenny Y. Xue
    Agnes Ang
    Jessica Lucas
    Trang T. Mai
    Arnaud F. Da Cruz Paula
    Anne Y. Saiki
    Deanna Mohn
    Pragathi Achanta
    Ann E. Sisk
    Kanika S. Arora
    Rohan S. Roy
    Dongsung Kim
    Chuanchuan Li
    Lee P. Lim
    Mark Li
    Amber Bahr
    Brian R. Loomis
    Elisa de Stanchina
    Jorge S. Reis-Filho
    Britta Weigelt
    Michael Berger
    Gregory Riely
    Kathryn C. Arbour
    J. Russell Lipford
    Bob T. Li
    Piro Lito
    Nature, 2021, 599 : 679 - 683
  • [28] Treatment-refractory colorectal cancer with KRAS G12C mutation
    Hartmann, Milan J. M.
    Alakus, Hakan
    ONKOLOGIE, 2024, : 521 - 522
  • [29] Targeting the KRAS G12C Mutation in Patients With Advanced Solid Tumors
    Hong, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 612 - 614
  • [30] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Zhao, Yulei
    Murciano-Goroff, Yonina R.
    Xue, Jenny Y.
    Ang, Agnes
    Lucas, Jessica
    Mai, Trang T.
    Da Cruz Paula, Arnaud F.
    Saiki, Anne Y.
    Mohn, Deanna
    Achanta, Pragathi
    Sisk, Ann E.
    Arora, Kanika S.
    Roy, Rohan S.
    Kim, Dongsung
    Li, Chuanchuan
    Lim, Lee P.
    Li, Mark
    Bahr, Amber
    Loomis, Brian R.
    de Stanchina, Elisa
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Berger, Michael
    Riely, Gregory
    Arbour, Kathryn C.
    Lipford, J. Russell
    Li, Bob T.
    Lito, Piro
    NATURE, 2021, 599 (7886) : 679 - +
12345